Statement concerning Nestlé Chairman

Apr 11, 2014

The Nestlé Board of Directors was informed yesterday that Peter Brabeck-Letmathe, Chairman of the Board, has been diagnosed with an illness which is curable but requires periodic medical treatment over the next six months.

This does not affect Mr. Brabeck-Letmathe’s ability to carry out his role as Chairman of the Nestlé Board of Directors and he will continue to fully exercise his duties during the treatment period.

Read the statement in French and German (pdf, 50 Kb).